Team

Andrew Baker

Partner

Dr Andrew Baker joined GBS in 2002 with over 18 years experience in the pharmaceutical and biotechnology industries, including 14 years working with industry leaders Genentech, Bayer and Johnson & Johnson. While working in the United States, Andrew had key responsibilities that included directing pharmaceutical and biotechnology research, and identifying and evaluating technology opportunities. Andrew is on the board of GBS portfolio companies Hatchtech Pty Ltd, Spinifex Pty Ltd, Verva Ltd, and Xenome Ltd.

Andrew earned a Bachelor of Science (Genetics) degree with honours from the University of Sydney and a Doctorate of Philosophy from the Australian National University in Canberra.